APA
da Costa W. H., Fares A. F., Bezerra S. M., Morini M. A., de Toledo Benigno L. A., Clavijo D. A., Fornazieri L., Rocha M. M., da Cunha I. W. & de Cassio Zequi S. (20190305). Loss of BAP1 expression in metastatic tumor tissue is an event of poor prognosis in patients with metastatic clear cell renal cell carcinoma. : Urologic oncology.
Chicago
da Costa Walter Henriques, Fares Aline Fusco, Bezerra Stephania M, Morini Mariana A, de Toledo Benigno Ligia Alencar, Clavijo Diego Abreu, Fornazieri Lucas, Rocha Maurício Murce, da Cunha Isabela Werneck and de Cassio Zequi Stenio. 20190305. Loss of BAP1 expression in metastatic tumor tissue is an event of poor prognosis in patients with metastatic clear cell renal cell carcinoma. : Urologic oncology.
Harvard
da Costa W. H., Fares A. F., Bezerra S. M., Morini M. A., de Toledo Benigno L. A., Clavijo D. A., Fornazieri L., Rocha M. M., da Cunha I. W. and de Cassio Zequi S. (20190305). Loss of BAP1 expression in metastatic tumor tissue is an event of poor prognosis in patients with metastatic clear cell renal cell carcinoma. : Urologic oncology.
MLA
da Costa Walter Henriques, Fares Aline Fusco, Bezerra Stephania M, Morini Mariana A, de Toledo Benigno Ligia Alencar, Clavijo Diego Abreu, Fornazieri Lucas, Rocha Maurício Murce, da Cunha Isabela Werneck and de Cassio Zequi Stenio. Loss of BAP1 expression in metastatic tumor tissue is an event of poor prognosis in patients with metastatic clear cell renal cell carcinoma. : Urologic oncology. 20190305.